Multiple-dose pharmacokinetics and pharmacodynamics of sergliflozin etabonate, a novel inhibitor of glucose reabsorption, in healthy overweight and obese subjects: a randomized double-blind study (Q43143768)

From Wikidata
Jump to navigation Jump to search
scientific article published on 3 March 2010
edit
Language Label Description Also known as
English
Multiple-dose pharmacokinetics and pharmacodynamics of sergliflozin etabonate, a novel inhibitor of glucose reabsorption, in healthy overweight and obese subjects: a randomized double-blind study
scientific article published on 3 March 2010

    Statements

    Multiple-dose pharmacokinetics and pharmacodynamics of sergliflozin etabonate, a novel inhibitor of glucose reabsorption, in healthy overweight and obese subjects: a randomized double-blind study (English)
    Elizabeth K Hussey
    Robert L Dobbins
    Randall R Stoltz
    Nancy L Stockman
    Robin L O'Connor-Semmes
    Anita Kapur
    Sharon C Murray
    Debbi Layko
    Derek J R Nunez
    3 March 2010
    636-646

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit